Influence of neurologic manifestations of primary human immunodeficiency virus infection on disease progression. SEROCO Study Group.
To determine the influence of neurologic manifestations of primary human immunodeficiency virus (HIV) infection on disease progression, 277 nonhemophiliac adults enrolled < 1 year after HIV infection were studied. Patients with neurologic manifestations during symptomatic primary HIV infection (PSI) (group N+; n = 23), with nonneurologic manifestations (group N-; n = 112) during PSI, and without any clinical manifestation during primary infection (group NPI; n = 142) were compared for disease progression. Age at infection, sex, mode of infection and CD4+ cell count at first visit did not differ between groups. In a Cox model, the relative risk (RR) of developing AIDS was 6.11 (95% confidence interval [CI], 1.94-19.28) in group N+ and 2.32 (95% CI, 0.93-5.83) in group N- compared with group NPI. The RR of AIDS onset after adjustment for treatment and age at infection was, respectively, 4.65 (95% CI, 1.43-15.03) and 2.03 (95% CI, 0.80-5.19) in groups N+ and N-. Neurologic manifestations of primary HIV infection are associated with an accelerated progression of disease.
Boufassa
F
F
SEROCO and HEMOCO Adult Cohorts, INSERM U 292, Les Cabanons Hôpital de Bicetre, Le Kremlin-Bicêtre, France.
Bachmeyer
C
C
Carré
N
N
Deveau
C
C
Persoz
A
A
Jadand
C
C
Séréni
D
D
Bucquet
D
D
D000328:Adult; D016516:CD4-CD8 Ratio; D018450:Disease Progression; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000276:immunology / Q000503:physiopathology*; D006801:Humans; D008297:Male; D009422:Nervous System Diseases / Q000209:etiology*; D011446:Prospective Studies; D012307:Risk Factors